In ER-positive breast cancer, AR functions as a tumor suppressor by inhibiting cell proliferation and interfering with ER signaling via competitive binding to the estrogen response element—a concept supported by a meta-analysis [40]. This evidence concerns the gene ESR1 and neoplasm.